药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02359 药明康德

已收盘 12-15 16:08:35

102.500

-2.600

-2.47%

最高104.900	最低101.700	成交量256.48万
今开103.400	昨收105.100	日振幅3.04%
总市值3,059亿	流通市值523.24亿	总股本29.84亿
成交额2.63亿	换手率0.50%	流通股本5.10亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":102.5,"timestamp":1765786115005,"preClose":105.1,"halted":0,"volume":2564753,"delay":0,"floatShares":510476909,"shares":2984000000,"eps":3.0317023315278298,"marketStatus":"已收盘","change":-2.6,"latestTime":"12-15 16:08:35","open":103.4,"high":104.9,"low":101.7,"amount":263323446,"amplitude":0.030447,"askPrice":102.5,"askSize":12000,"bidPrice":102.4,"bidSize":3300,"shortable":3,"etf":0,"ttmEps":5.14445770659009,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":105.1,"dividendRate":0.014182,"openAndCloseTimeList":[[1765762200000,1765771200000],[1765774800000,1765785600000]],"volumeRatio":0.539907,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":91.21,"timestamp":1765782000000,"preClose":94.05,"halted":0,"volume":34165700,"delay":0,"premium":"+1.68"}},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"2591612626","title":"药明康德最新公告：出售资产交易完成交割预计产生税后净利润约9.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591612626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591612626?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:43","pubTimestamp":1765791794,"startTime":"0","endTime":"0","summary":"药明康德(603259.SH)公告称，公司全资子公司上海药明康德新药开发有限公司已收到受让方支付的首期股权转让价款15.4亿元，《股权转让协议》约定的交割先决条件已满足，本次交易已完成交割，目标公司不再纳入公司合并报表范围。预计本次交易将产生税后净利润约9.6亿元，占公司最近一期（2024年度）经审计归母净利润的比例超过10%。目标公司及相关各方将按协议约定办理市监局变更登记手续，预计2025年12月31日之前完成变更登记。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603259","02359"],"gpt_icon":0},{"id":"2591616750","title":"智通AH统计|12月15日","url":"https://stock-news.laohu8.com/highlight/detail?id=2591616750","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591616750?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:15","pubTimestamp":1765786506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止12月15日收盘，东北电气、京城机电股份、弘业期货分列AH溢价率前三位，溢价率分别为900.00%、266.67%、265.78%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-11.03%、-0.77%、1.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01618","00317","00038","02218","00548","00553","01812","02338","BK1562","IE00B29SXG58.USD","03143","LU1504937902.USD","01349","03750","BK1594","399300","00916","00177","BK1565","01339","02359","01528","01057","03678","03968","06826","159982","01988","LU0244354667.USD","01108","LU0823426480.USD","02238","02865","LU0886674414.USD","06818","00300","LU0348827113.USD","LU1105468828.SGD","LU1522347837.USD","00638","02899","01033","03606","01276","00042","06127","00187"],"gpt_icon":1},{"id":"2591663796","title":"医疗与消费周报：创新药行业研发突破与市场演进的并行","url":"https://stock-news.laohu8.com/highlight/detail?id=2591663796","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591663796?lang=zh_cn&edition=full","pubTime":"2025-12-14 16:08","pubTimestamp":1765699711,"startTime":"0","endTime":"0","summary":"投资要点：近期观点1、医药指数本周关注的6个子行业只有一个录得正收益。新药分为强调全新结构的1类（创新药）与强调临床优势的2类。近年来产业规模持续扩大，从2020年约8198亿元增至2024年1.14万亿元，年均复合增长率达8.53%，预计2025年将达1.22万亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214160834a44985a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214160834a44985a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01276","LU0588546209.SGD","BK1574","LU1719994722.HKD","LU1969619763.USD","02359","BK1583","06978","06160","BK1500","LU2328871848.SGD","LU1303224171.USD","BK1588","LU0307460666.USD","LU1251922891.USD","LU1770034418.SGD"],"gpt_icon":0},{"id":"2591657917","title":"医药行业周报：IN VIVO CART：BD热门赛道 早期技术具备广阔前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2591657917","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591657917?lang=zh_cn&edition=full","pubTime":"2025-12-14 00:00","pubTimestamp":1765641600,"startTime":"0","endTime":"0","summary":"核心观点：In Vivo CART赛道发展火热，2025年已经有四个MNC并购的案例发生。具体来看，In Vivo CART分为LNP和慢病毒两条技术路线，两条技术路线均具备显著特色。LNP路线来看，药物在临床前展现出了快速转染以及优异的靶向性特点，慢病毒路线中，Esobiotec等公司的BCMA In Vivo CART已经在小人群MM患者中展现非常好的早期数据。整体看，In VivoCART发展迅速，后续发展值得关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","LU2242644610.SGD","06821","LU0052750758.USD","06160","LU0708995583.HKD","BK1141","LU0320764599.SGD","02359","01801","LU2125910500.SGD","BK1583","BK1574","LU2045819591.USD","01177","BK1576","LU1046422090.SGD","BK1161"],"gpt_icon":0},{"id":"2591632904","title":"英伟达连续布局13家企业，AI制药3个方向梳理（附列表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2591632904","media":"投研大叔","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591632904?lang=zh_cn&edition=full","pubTime":"2025-12-13 19:40","pubTimestamp":1765626014,"startTime":"0","endTime":"0","summary":"今天介绍下AI制药，英伟达在过去2年投资13家AI药企，推出BioNeMo生物分子AI框架已经覆盖上百家药企，英硅智能ISM001-055进入临床III期，成为首个跨越临床II期的AI药物，从之前的布局到如今逐渐突破，商业价值正在逐渐被验证。从大叔个人来看，还有一些罕见病，由于患者少，研发不划算，而AI能快速低成本设计药物，让更多罕见病有药可治。近期热门文章HW组建医疗卫生军团，AI医疗爆发！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVD2.UK","02196","NVDD","LU2860962120.EUR","03759","LU0157215616.USD","LU0096362180.USD","SNVD.UK","LU2505996509.AUD","LU2505996681.GBP","LU2191332357.HKD","LU0158827948.USD","LU2237438978.USD","NVDY","LU1496350171.SGD","NVDA","IE0034235188.USD","LU1914381329.SGD","06821","LU0274383776.USD","IE00BDCRKT87.USD","NVD","SGXZ81514606.USD","LU1839511570.USD","LU2602419157.SGD","NVIW.SI","SG9999004303.SGD","LU2089284900.SGD","IE000ITXATA3.USD","LU1145028129.USD","LU1280957306.USD","2NVD.UK","LU0719512351.SGD","LU1988902786.USD","02359","LU2463028550.USD","LU2249611893.SGD","LU2473716301.USD","LU0320765059.SGD","NVDS","NVDX","LU2065171311.SGD","02228","NVD3.UK","NVDU","01093","IE000YTNTUN2.SGD","LU0444973449.USD","3NVD.UK","LU0308772762.SGD","LU1642822529.SGD","IE00BJJMRY28.SGD","LU2592432038.USD","06127","LU2420271590.USD","NVDS.UK"],"gpt_icon":1},{"id":"2590579662","title":"智通AH统计|12月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2590579662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590579662?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:15","pubTimestamp":1765527305,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止12月12日收盘，东北电气、浙江世宝、京城机电股份分列AH溢价率前三位，溢价率分别为900.00%、265.58%、262.47%；宁德时代、招商银行、潍柴动力分列AH溢价率末三位，溢价率分别为-9.05%、-2.65%、6.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03678","00042","01349","00553","01618","02338","LU0348735423.USD","159982","LU0348788117.USD","00187","01456","00548","06031","LU0054450605.USD","00916","00895","01812","02238","LU1504937902.USD","399300","02359","01528","BK1522","LU0862451753.SGD","06818","00038","02727","03968","01988","00317","06127","00638","01033","LU0211977185.USD","01057","03750","01108","02218","IE00B031J352.USD","06826","LU1993786604.SGD","BK1539","03143","02899","00300","06655","03606","06099"],"gpt_icon":1},{"id":"2590117529","title":"每日卖空追踪 | 药明康德 12月11日卖空量成交29.61万股，卖空比例为6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590117529","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590117529?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:30","pubTimestamp":1765441828,"startTime":"0","endTime":"0","summary":"药明康德北京时间12月11日，涨0.67%，卖空量成交29.61万股，较上一交易日减少65.32%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163502a6991505&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163502a6991505&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU0052750758.USD","02359","LU2242644610.SGD","LU0708995583.HKD","LU1046422090.SGD","BK1576","LU2125910500.SGD","BK1141","LU0320764599.SGD","LU2045819591.USD"],"gpt_icon":0},{"id":"2590529159","title":"药明康德12月11日获主力加仓3040.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590529159","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590529159?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440907,"startTime":"0","endTime":"0","summary":"12月11日, 药明康德股价涨0.67%，报收105.00元，成交金额4.9亿元，换手率0.90%，振幅3.55%，量比0.82。药明康德今日主力资金净流入3040.7万元，上一交易日主力净流入796.8万元。该股近5个交易日上涨2.14%，主力资金累计净流入1.1亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入9.1亿元，其中净流入天数为18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121116154795375244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121116154795375244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","LU0052750758.USD","LU1046422090.SGD","LU2045819591.USD","BK1583","LU2125910500.SGD","BK1576","LU2242644610.SGD","LU0708995583.HKD","02359","BK1141"],"gpt_icon":0},{"id":"2590592453","title":"诺华领跑，药明康德狂飙！小核酸药物市场井喷，中国CDMO产业链迎来爆发式增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2590592453","media":"摩熵医药","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590592453?lang=zh_cn&edition=full","pubTime":"2025-12-11 10:26","pubTimestamp":1765419964,"startTime":"0","endTime":"0","summary":"2016年后，多款重磅小核酸药物陆续上市，在遗传罕见病和慢性病等领域取得重大突破，全球小核酸药物市场进入高速增长通道。近年来，中国小核酸领域的BD交易异常活跃。根据2025年中期报告，包含寡核苷酸、多肽等在内的化学大分子CDMO业务板块，收入达3.79亿元，同比增速超过130%。随着小核酸药物商业化的加速，国内CDMO企业迎来确定性的增长机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211102610a4414f91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211102610a4414f91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","BK1191","LU0320764599.SGD","LU2045819591.USD","BK1583","LU1046422090.SGD","LU2242644610.SGD","LU2125910500.SGD","LU0708995583.HKD","06821","02359","LU0052750758.USD"],"gpt_icon":1},{"id":"2590589802","title":"Qatar Investment Authority减持药明康德(02359)86.94万股 每股作价为约102.77港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590589802","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590589802?lang=zh_cn&edition=full","pubTime":"2025-12-10 19:07","pubTimestamp":1765364876,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，12月5日，Qatar Investment Authority减持药明康德(02359)86.94万股，每股作价为102.7651港元，总金额约为8934.4万港元。减持后最新持股数目为2989.57万股，持股比例为5.86%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1046422090.SGD","LU1979443071.USD","LU0052750758.USD","LU2045819591.USD","BK0216","LU2125910500.SGD","BK1583","LU1934453819.USD","LU1997244956.HKD","LU1997245094.SGD","603259","LU1997245177.USD","LU0320764599.SGD","02359","LU1808992512.USD","LU2495084118.USD","LU2488822045.USD","BK1576","LU2242644610.SGD","LU2328871848.SGD","LU1969619763.USD","BK1141","LU0708995583.HKD","LU0456842615.SGD"],"gpt_icon":0},{"id":"2590303708","title":"重磅事件落地！商业化+出海提速，板块调整后弹性更突出","url":"https://stock-news.laohu8.com/highlight/detail?id=2590303708","media":"浙商证券融资融券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590303708?lang=zh_cn&edition=full","pubTime":"2025-12-10 13:02","pubTimestamp":1765342962,"startTime":"0","endTime":"0","summary":"关注研发实力强且已有商业化创新药产品上市的企业；CXO及生命科学上游产业链。CXO一体化龙头公司如药明康德，保持业绩持续向好趋势，业绩保持较快增长。投资者据此操作，风险自负。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512101335329534f1c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512101335329534f1c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06160","06821","BK1141","BK1574","LU1046422090.SGD","LU2045819591.USD","06978","02268","LU0052750758.USD","03759","BK1576","LU2125910500.SGD","02359","LU2242644610.SGD","BK1161","LU0708995583.HKD","LU0320764599.SGD","01801"],"gpt_icon":0},{"id":"2590930370","title":"辉瑞与药明康德达成独家合作及许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2590930370","media":"新浪财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590930370?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:33","pubTimestamp":1765280001,"startTime":"0","endTime":"0","summary":"辉瑞与 药明康德 达成独家合作及许可协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209193925a72d556f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209193925a72d556f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK1576","LU0052750758.USD","02359","LU2125910500.SGD","BK1141","LU2045819591.USD","LU2242644610.SGD","LU1046422090.SGD","LU0708995583.HKD","BK1583"],"gpt_icon":0},{"id":"2590037033","title":"高瓴28亿后再收购，CXO拐点已至？","url":"https://stock-news.laohu8.com/highlight/detail?id=2590037033","media":"动脉网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590037033?lang=zh_cn&edition=full","pubTime":"2025-12-09 17:09","pubTimestamp":1765271340,"startTime":"0","endTime":"0","summary":"12月3日，高瓴资本全资收购南京明捷生物医药检测有限公司，12月4日药明康德A股、港股股价皆升。60天前，高瓴刚以28亿元收购药明康德旗下两家公司，此次已是两个月内第三次接盘药明康德资产。高瓴曾是药明康德早期投资方，2021年后陆续减持引发“退出医药赛道”猜测，如今却持续加码国内医药外包服务领域。明捷医药成立于2016年，是国际化药物质量研究服务提供商，在南京和上海设有实验室，2023年通过美国FDA现场检查，服务覆盖研发到上市放行全流程，累计服务超1000家客户，完成5000+个项目。2020年其被药明康德收购，2025年12月3日又被出售给高瓴，且这只是药明康德“战略瘦身”计划最新一环。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120917182797983bf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120917182797983bf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU0052750758.USD","BK1576","LU2125910500.SGD","LU0320764599.SGD","02359","LU1046422090.SGD","BK1141","LU2242644610.SGD","LU0708995583.HKD","LU2045819591.USD"],"gpt_icon":0},{"id":"2590303776","title":"每日卖空追踪 | 药明康德 12月09日卖空量成交36.28万股，卖空比例为8.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590303776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590303776?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:30","pubTimestamp":1765269029,"startTime":"0","endTime":"0","summary":"药明康德北京时间12月09日，涨1.06%，卖空量成交36.28万股，较上一交易日减少11.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209163432a72cf25a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209163432a72cf25a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU0320764599.SGD","BK1576","LU2045819591.USD","LU0052750758.USD","LU1046422090.SGD","LU2125910500.SGD","LU2242644610.SGD","LU0708995583.HKD","BK1141","02359"],"gpt_icon":0},{"id":"2590303705","title":"药明康德25年：穿越周期的韧性","url":"https://stock-news.laohu8.com/highlight/detail?id=2590303705","media":"财富在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590303705?lang=zh_cn&edition=full","pubTime":"2025-12-09 15:44","pubTimestamp":1765266279,"startTime":"0","endTime":"0","summary":"进入12月，药明康德迎来了成立的第25个年头。在这段发展历程中，药明康德用实践诠释了何谓穿越周期的“长期主义”。这种良性循环构成了药明康德的内生增长动力。根据其三季度财报，在此前12个月间，药明康德在R端合成并交付超过43万个小分子化合物。2025年三季度，药明康德持续经营业务在手订单接近600亿元，同比增长41.2%，为未来发展提供了坚实的确定性。这并非偶然，而是药明康德遵循严格质量体系的必然结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209160013a43d2b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209160013a43d2b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK1576","LU2242644610.SGD","LU1046422090.SGD","LU0708995583.HKD","LU2125910500.SGD","LU0052750758.USD","LU2045819591.USD","BK1141","02359","BK1583"],"gpt_icon":0},{"id":"2590348233","title":"中信证券：医保谈判成功率创近年新高，关注创新药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2590348233","media":"瑞财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590348233?lang=zh_cn&edition=full","pubTime":"2025-12-09 14:57","pubTimestamp":1765263437,"startTime":"0","endTime":"0","summary":"瑞财经 严明会近日，中信证券指出，2025年12月7日，2025创新药高质量发展大会在广州举行，国家医保局现场发布了2025年《国家基本医疗保险、生育保险和工伤保险药品目录》及《商业健康保险创新药品目录》。在基本医保目录上，最终114个成功纳入，其中包含50个1类创新药，成功率为88%，谈判成功率创近7年新高。与此同时，首版商保目录发布，共纳入19款产品，包含5款CAR-T产品。中信证券认为，伴随着国家对创新药持续的政策倾斜和鼓励支持，医保和商保的双轨并行，有望带动支付多元化，创新药企的回报有望逐步提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512091457209532ed86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512091457209532ed86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","02359","06160","BK4526","BK4139","BK4585"],"gpt_icon":0},{"id":"2590397917","title":"招银国际：中国医药业板块行情或将分化 关注个股机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2590397917","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590397917?lang=zh_cn&edition=full","pubTime":"2025-12-09 13:52","pubTimestamp":1765259532,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，MSCI中国医疗指数2025年初至今累计上涨62.8%，跑赢MSCI中国指数32.2%。预期在行业估值已经大幅修复的基础上，2026年医药行业较难出现普涨的机会，然而部分个股存在估值和业绩修复的机会，例如医疗服务、制药、CXO等个股。展望2026年，该行认为，中国创新药出海BD趋势仍将延续。医药研发需求复苏，带动CXO行业景气度提升医药研发需求在2025年开启复苏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","LU2125910500.SGD","BK1583","06978","02359","03759","LU0052750758.USD","BK1141","BK1161","LU0320764599.SGD","LU0708995583.HKD","LU2242644610.SGD","BK1574","LU1046422090.SGD","LU2045819591.USD","09939","BK1515"],"gpt_icon":0},{"id":"2589818225","title":"12月5日港股药品及生物科技行业沽空数据盘点，信达生物、翰森制药、药明康德沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2589818225","media":"证券之星APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589818225?lang=zh_cn&edition=full","pubTime":"2025-12-05 18:06","pubTimestamp":1764929210,"startTime":"0","endTime":"0","summary":"证券之星消息，12月5日港交所披露数据显示，当日港股药品及生物科技行业的159只个股中有82只被沽空，总沽空股数为9183.67万股，总沽空金额为27.5亿元（港元），而当日药品及生物科技行业的总成交金额为126.22亿元（港元），沽空比例为21.79%。当日药品及生物科技行业总体涨0.07%。从沽空金额来看，信达生物、翰森制药、药明康德沽空金额位居行业前三，分别为11.43亿港元、3.46亿港元、2.49亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205181415952ca0ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205181415952ca0ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU2097828805.USD","BK1576","LU0455707207.USD","LU0502904849.HKD","LU2097828631.EUR","LU2125910500.SGD","LU1969619763.USD","01801","LU2097828714.EUR","BK1191","LU2045819591.USD","LU2097828474.EUR","BK1589","LU2242644610.SGD","LU1046422090.SGD","BK1161","LU0708995583.HKD","LU0052750758.USD","BK1583","LU2328871848.SGD","BK1141","03692","LU0320764599.SGD","LU2097828557.USD","HK0000165453.HKD","02359"],"gpt_icon":0},{"id":"2589818212","title":"每日卖空追踪 | 药明康德 12月05日卖空量成交117.68万股，卖空比例为14.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589818212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589818212?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:30","pubTimestamp":1764923427,"startTime":"0","endTime":"0","summary":"药明康德北京时间12月05日，涨0.29%，卖空量成交117.68万股，较上一交易日减少8.76%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205163405a4ce66a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205163405a4ce66a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU0052750758.USD","LU1046422090.SGD","LU0708995583.HKD","02359","LU2045819591.USD","LU2125910500.SGD","LU2242644610.SGD","BK1141","LU0320764599.SGD","BK1583"],"gpt_icon":0},{"id":"2589589618","title":"“华润系”又卖掉一家药企！医药行业企业集体“减负”","url":"https://stock-news.laohu8.com/highlight/detail?id=2589589618","media":"中国制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589589618?lang=zh_cn&edition=full","pubTime":"2025-12-05 14:04","pubTimestamp":1764914687,"startTime":"0","endTime":"0","summary":"至此， 金种子酒 不再持有金太阳药业股权，金太阳药业不再纳入其合并报表范围。今年以来，“华润系”频繁出售非核心资产。一场“减负”潮席卷医药行业。业内表示，这场行业“减负”潮，本质上是医药行业的一次自我优化与升级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205140900a7253e36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205140900a7253e36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","BK1588","BK1191","01109","BK1587","02196","00013"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":0.0204},{"period":"1month","weight":0.0375},{"period":"3month","weight":-0.0506},{"period":"6month","weight":0.3232},{"period":"1year","weight":0.8888},{"period":"ytd","weight":0.9088}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.012449},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.006618},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.010471},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015053},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.001001},{"month":6,"riseRate":0.714286,"avgChangeRate":0.076679},{"month":7,"riseRate":0.714286,"avgChangeRate":0.099103},{"month":8,"riseRate":0.571429,"avgChangeRate":0.042308},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002335},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.002939},{"month":12,"riseRate":0.714286,"avgChangeRate":0.047272}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}